{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:56:11Z","timestamp":1793339771306,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":119,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"funder":[{"DOI":"10.13039\/501100007901","name":"Microbiology Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antimicrobial resistance (AMR) is a global threat that requires innovative solutions to protect our future and avoid repeating the mistakes of our past. To do this, innovation and regulation need to work together to deliver new therapeutics, diagnostics, and vaccines in a timely and risk-proportionate manner. Funders recognize that providing product developers with access to technical, regulatory, and experiential knowledge derisks their investment and maximizes the likelihood of success. The Global Antimicrobial Innovation Fund (GAMRIF) is a global funder in AMR innovation across One Health with a Lower Middle-Income Country focus; in 2024, it increased its innovator support structure to include a regulatory science team at the Medicines and Healthcare products Regulatory Agency (MHRA). As part of its discovery work, the GAMRIF\u2013MHRA team held a 2-day meeting convening innovators, product developers, manufacturers, regulators, funders, and access and policy experts to interrogate the product journey across development, regulation, manufacturing, and market access to identify common challenges and generate practical solutions to address them. Here we present a summary of the meeting content, and recommendations and next steps based on delegate engagement and feedback.<\/jats:p>","DOI":"10.1093\/sumbio\/qvag016","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:35:39Z","timestamp":1777563339000},"source":"Crossref","is-referenced-by-count":1,"title":["Community-driven solutions for the AMR problem: outcomes from a regulator\u2013innovator workshop on challenges across AMR innovation, access, and adoption"],"prefix":"10.1093","volume":"3","author":[{"given":"Leanne","family":"Cleaver","sequence":"first","affiliation":[{"name":"MHRA Science Campus , Blanche Lane, South Mimms, Hertfordshire, EN6 3QG ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lamaudiere","sequence":"additional","affiliation":[{"name":"MHRA Science Campus , Blanche Lane, South Mimms, Hertfordshire, EN6 3QG ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Almond","sequence":"additional","affiliation":[{"name":"MHRA Science Campus , Blanche Lane, South Mimms, Hertfordshire, EN6 3QG ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8694-4894","authenticated-orcid":false,"given":"Carmen H","family":"Coxon","sequence":"additional","affiliation":[{"name":"MHRA Science Campus , Blanche Lane, South Mimms, Hertfordshire, EN6 3QG ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2026061104264266100_bib2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41541-025-01068-2","article-title":"Recombinant production platform for group a Streptococcus glycoconjugate vaccines","volume":"10","author":"Ajay","year":"2025","journal-title":"NPJ Vaccines"},{"key":"2026061104264266100_bib3","volume-title":"Leaving the Lab: Tracking the Decline in AMR R&D Professionals","author":"Alliance","year":"2024"},{"key":"2026061104264266100_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial\u00a0Resistance","year":"2022","journal-title":"Lancet"},{"key":"2026061104264266100_bib5","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S0140-6736(23)00282-9","article-title":"Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation","volume":"403","author":"\u00c5rdal","year":"2024","journal-title":"Lancet"},{"key":"2026061104264266100_bib6","doi-asserted-by":"publisher","first-page":"e014605","DOI":"10.1136\/bmjgh-2023-014605","article-title":"Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: a commentary on the proposed EU pharma regulation","volume":"9","author":"Berner-Rodoreda","year":"2024","journal-title":"BMJ Glob Health"},{"key":"2026061104264266100_bib7","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3390\/microorganisms11102496","article-title":"Wastewater surveillance in europe for non-polio enteroviruses and beyond","volume":"11","author":"Bubba","year":"2023","journal-title":"Microorganisms"},{"key":"2026061104264266100_bib8","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1016\/j.vaccine.2022.08.064","article-title":"Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS colonisation of vaginal epithelial cells","volume":"40","author":"Deifallah","year":"2022","journal-title":"Vaccine"},{"key":"2026061104264266100_bib9","doi-asserted-by":"publisher","DOI":"10.1002\/puh2.70034","article-title":"Antibiotic resistance in developing countries: emerging threats and policy responses","volume":"4","author":"Ehsan","year":"2025","journal-title":"Public Health Chall"},{"key":"2026061104264266100_bib35_517_265226","doi-asserted-by":"publisher","first-page":"102562","DOI":"10.1016\/j.mib.2024.102562","article-title":"Important challenges to finding new leads for new antibiotics","volume":"83","author":"Farha","year":"2025","journal-title":"Curr Opin Microbiol"},{"key":"2026061104264266100_bib11","article-title":"Guidance for Industry PAT\u2014a Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance","author":"FDA","year":"2004"},{"key":"2026061104264266100_bib12","doi-asserted-by":"publisher","first-page":"103485","DOI":"10.1016\/j.eclinm.2025.103485","article-title":"Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27","volume":"88","author":"Goh","year":"2025","journal-title":"EClinMed"},{"key":"2026061104264266100_bib13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jcv.2018.01.008","article-title":"Recommendations for enterovirus diagnostics and characterisation within and beyond Europe","volume":"101","author":"Harvala","year":"2018","journal-title":"J Clin Virol"},{"key":"2026061104264266100_bib14","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3390\/vaccines11111724","article-title":"Mucosal immunization has benefits over traditional subcutaneous immunization with group a streptococcus antigens in a pilot study in a mouse model","volume":"11","author":"Helen","year":"2023","journal-title":"Vaccines"},{"key":"2026061104264266100_bib15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/cpt.1367","article-title":"Regulation and innovation: role of regulatory science in facilitating pharmaceutical innovation","volume":"105","author":"Honig","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2026061104264266100_bib16","author":"ICARS"},{"key":"2026061104264266100_bib17","article-title":"Pharmaceutical Development Q8(R2)","author":"ICH","year":"2009"},{"key":"2026061104264266100_bib18","article-title":"Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides","volume":"20","author":"Kirsty\u00a0Le\u00a0Doare","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"2026061104264266100_bib19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40258-022-00786-1","article-title":"Can the UK \u2018Netflix\u2019 payment model boost the antibacterial pipeline?","volume":"21","author":"Leonard","year":"2023","journal-title":"Appl Health Econ Health Policy"},{"key":"2026061104264266100_bib20","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/S0140-6736(24)00862-6","article-title":"Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis","volume":"403","author":"Lewnard","year":"2024","journal-title":"Lancet"},{"key":"2026061104264266100_bib21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/v13020249","article-title":"High diversity of human non-polio enterovirus serotypes identified in contaminated water in Nigeria","volume":"13","author":"Majumdar","year":"2021","journal-title":"Viruses"},{"key":"2026061104264266100_bib22","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/v12101144","article-title":"Tracking SARS-CoV-2 in sewage: evidence of changes in virus variant predominance during COVID-19 pandemic","volume":"12","author":"Martin","year":"2020","journal-title":"Viruses"},{"key":"2026061104264266100_bib23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","article-title":"Towards the sustainable discovery and development of new antibiotics","volume":"5","author":"Miethke","year":"2021","journal-title":"Nat Rev Chem"},{"key":"2026061104264266100_bib24","article-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations","author":"O\u2019Neill","year":"2016"},{"key":"2026061104264266100_bib25","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1473-3099(16)30127-X","article-title":"Reflecting on the final report of the O\u2019Neill review on antimicrobial resistance","volume":"16","author":"Piddock","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2026061104264266100_bib26","volume-title":"The Future of Technological Innovations and the Role of Regulation","author":"RHC","year":"2025"},{"key":"2026061104264266100_bib27","article-title":"the role of regulators in mitigating uncertainty within the Valley of Death","volume":"109","author":"Roca","year":"2022","journal-title":"Technovation"},{"key":"2026061104264266100_bib28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fbioe.2020.00258","article-title":"A methodological safe-by-design approach for the development of nanomedicines","volume":"8","author":"Schmutz","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"2026061104264266100_bib29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s40168-022-01313-z","article-title":"Developing whole cell standards for the microbiome field","volume":"10","author":"Sergaki","year":"2022","journal-title":"Microbiome"},{"key":"2026061104264266100_bib1","article-title":"Shionogi, GARDP and CHAI announce landmark license and collaboration agreements to treat bacterial infections by expanding access to cefiderocol in 135 countries","year":"2022"},{"key":"2026061104264266100_bib30","doi-asserted-by":"publisher","first-page":"e0035625","DOI":"10.1128\/msphere.00356-25","article-title":"Cross-comparison study of three ELISA methodologies to measure Shigella Sonnei O-antigen serum IgG","volume":"10","author":"Stickings","year":"2025","journal-title":"mSphere"},{"key":"2026061104264266100_bib31","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1016\/j.vaccine.2018.05.073","article-title":"Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: a collaborative study","volume":"37","author":"Studholme","year":"2019","journal-title":"Vaccine"},{"key":"2026061104264266100_bib32","article-title":"New Approach to Ensure Regulators and Regulation Support Growth","author":"Treasury","year":"2025"},{"key":"2026061104264266100_bib33","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"key":"2026061104264266100_bib34","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1016\/j.vaccine.2018.06.038","article-title":"Development and validation of a monocyte activation test for the control\/safety testing of an OMV-based meningococcal B vaccine","volume":"37","author":"Vipond","year":"2019","journal-title":"Vaccine"},{"key":"2026061104264266100_bib35","doi-asserted-by":"publisher","first-page":"e000511","DOI":"10.1136\/bmjph-2023-000511","article-title":"Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis","volume":"3","author":"Zay","year":"2025","journal-title":"BMJ Public Health"}],"container-title":["Sustainable Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sumbio\/advance-article-pdf\/doi\/10.1093\/sumbio\/qvag016\/68195570\/qvag016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sumbio\/article-pdf\/3\/2\/qvag016\/68195570\/qvag016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sumbio\/article-pdf\/3\/2\/qvag016\/68195570\/qvag016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:26:53Z","timestamp":1781166413000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sumbio\/article\/doi\/10.1093\/sumbio\/qvag016\/8665780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/sumbio\/qvag016","relation":{},"ISSN":["2755-1970"],"issn-type":[{"value":"2755-1970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"qvag016"}}